Skip to main content

Table 4 Population attributable risk of all-cause mortality and CVD hospitalization, associated to HbA1c > 6.5%

From: Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study

  All-cause mortality CHD hospitalization Stroke hospitalization
Cases/Non-cases 499/18,598 912/18,185 786/18,311
RR 1.29 (1.08, 1.55) 1.38 (1.2, 1.59) 1.05 (0.91, 1.21)
PAR % 13.62 (3.96, 22.90) 17.90 (10.53, 25.20) 2.64 (−5.51, 10.76)
  1. Model is fully adjusted for age (restricted quadratic splines with 5 knots), sex, smoking status (never, former, current), obesity (no, yes), hypertension (no, yes), chronic kidney disease (no, yes), anti-hypertensive medication (no, yes), glucose lowering medication (no, yes), lipid lowering medication (no, yes). The prevalence of glycated hemoglobin > 6.5% was 57.78%